Bio-Gene Technology Company Description
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally.
Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone.
The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activity of its molecules against a range of insect species; Advanced Molecular Technologies; CSIRO for a chemistry development process; the Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University for chemical analysis of natural products; University of Florida; and University of Technology.
It serves animal health, crop protection, grain storage, public health, and consumer applications. The company was incorporated in 1995 and is based in Melbourne, Australia.
| Country | Australia |
| Founded | 1995 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Timothy Grogan |
Contact Details
Address: 400 Collins Street Melbourne, VIC 3000 Australia | |
| Phone | 61 3 9068 1062 |
| Website | bio-gene.com.au |
Stock Details
| Ticker Symbol | BGT |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000BGT8 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Timothy Owen Grogan B.Sc., LLB | MD, Chief Executive Officer and Director |
| Drew Speedy AGIA, B.Bus, CPA | Chief Financial Officer and Company Secretary |
| Peter Donald May AFA1M, AFAIM, GAICD, M.B.A. | Executive Director of Research and Development and Executive Director |